Racial Differences in S100b Levels in Persons with Schizophrenia

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler · Schizophrenia Bulletin · 1987 · 21.4K citations · Full text

Social Sciences, Psychiatry, Psychology +17

Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

Stefan Leucht, Myrto Samara, Stephan Heres et al. · Schizophrenia Bulletin · 2016 · 744 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones

Johann Steiner, Hendrik Bielau, Bernstein Hg et al. · Journal of Neurology Neurosurgery & Psychiatry · 2006 · 121 citations · Full text

Life Sciences, Neuroscience, Psychiatry +16

Age-Related Changes of Neuron-Specific Enolase, S-100 Protein, and Myelin Basic Protein Concentrations in Cerebrospinal Fluid

Baziel G.M. van Engelen, K.J.B. Lamers, F.J.M. Gabreëls et al. · Clinical Chemistry · 1992 · 119 citations

Life Sciences, Neurology, Neuroscience +13

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

Ahmad A. Tarhini, Joseph Stuckert, Sandra Lee et al. · Journal of Clinical Oncology · 2008 · 115 citations · Full text

Medicine, Clinical Sciences, Oncology +17